In our series, nuclear accumulation of p53 protein, as a marker of p53 deficiency [20], was associated with an increase of NF-κB target genes in response to doxorubicin ex vivo. This evidence concerns the gene NFKB1 and hyperinsulinemic hypoglycemia, familial, 4.